Edmund Lacour, MD
Rheumatology · Dothan, ALNPI 1285689463
Payments from drug & device makers
Across 727 payments — averaging $451.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$318K
- Amgen$3K
- AbbVie$2K
- Novartis$2K
- Johnson & Johnson$715
- Aurinia Pharma U.S., Inc.$507
- plus $3K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 278 | $317,600 |
| Amgen(2 entities) | 143 | $2,560 |
| AbbVie | 130 | $2,005 |
| Novartis | 15 | $1,772 |
| Johnson & Johnson(2 entities) | 34 | $715 |
| Aurinia Pharma U.S., Inc. | 14 | $507 |
| Janssen Scientific Affairs, LLC | 4 | $351 |
| UCB, Inc. | 13 | $282 |
| Boehringer Ingelheim | 11 | $279 |
| Radius Health, Inc. | 7 | $266 |
| AstraZeneca | 3 | $257 |
| E.r. Squibb & Sons, L.L.C. | 11 | $248 |
| Lilly USA, LLC | 7 | $228 |
| Genentech USA, Inc. | 16 | $208 |
| Pfizer | 5 | $189 |
| GSK | 2 | $108 |
| ANI Pharmaceuticals, Inc. | 4 | $95 |
| Medtronic(2 entities) | 3 | $78 |
| Mallinckrodt Hospital Products Inc. | 3 | $61 |
| Corcept Therapeutics | 4 | $51 |
| Sanofi | 1 | $34 |
| Amarin Pharma, Inc. | 2 | $28 |
| Welch Allyn | 1 | $26 |
| Baxter Healthcare | 1 | $26 |
| Novo Nordisk | 2 | $24 |
| Smith+Nephew | 1 | $22 |
| Mallinckrodt Enterprises LLC | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Bioventus LLC | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Eisai Inc. | 1 | $12 |
| Merck | 1 | $12 |
How this compares
$328,211 in reported general payments places this provider in the 85th percentile of 90 rheumatology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Dothan
- Jeffrey CurtisBirmingham$17.6M
- Kenneth SaagBirmingham$8.2M
- Vishala ChindaloreAnniston$3.5M
- Anthony TurkiewiczMountain Brk$2.5M
- Harry SchroederBirmingham$938K
- Jose Rubio MosqueraBirmingham$823K
- David McLainBirmingham$588K
- William ShergyHuntsville$453K
- Ray McLaughinTuscaloosa$332K
- Richard JonesNorthport$290K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.